Description
Riesgo de síndrome de lisis tumoral
FORMA FARMACÉUTICA: 24 TABLETAS
Neutropenia
DOSIS: 5 MG
PRINCIPIO ACTIVO: TERBINAFINA CLORHIDRATO
SIG 2 5MG CPR C30 FERRER THERAPEUTICS SA DE CV Riesgo de síndrome de lisisPRINCIPIO ACTIVO: BISOPROLOL DOSIS: 2. 5 MG FORMA FARMACUTICA: 30 COMPRIMIDOS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
